Global POCT Molecular Diagnostics Technology Supply, Demand and Key Producers, 2023-2029

Global POCT Molecular Diagnostics Technology Supply, Demand and Key Producers, 2023-2029

The global POCT Molecular Diagnostics Technology market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global POCT Molecular Diagnostics Technology demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for POCT Molecular Diagnostics Technology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of POCT Molecular Diagnostics Technology that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global POCT Molecular Diagnostics Technology total market, 2018-2029, (USD Million)

Global POCT Molecular Diagnostics Technology total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: POCT Molecular Diagnostics Technology total market, key domestic companies and share, (USD Million)

Global POCT Molecular Diagnostics Technology revenue by player and market share 2018-2023, (USD Million)

Global POCT Molecular Diagnostics Technology total market by Type, CAGR, 2018-2029, (USD Million)

Global POCT Molecular Diagnostics Technology total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global POCT Molecular Diagnostics Technology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ustar Biotechnologies (Hangzhou) Ltd., Cepheid, Abbott Laboratories, Roche Holding AG, BioFire Diagnostics, Beijing Bohui Innovat Biotech Grp Co Ltd., CapitalBio Corporation, Daan Gene and Sansure Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World POCT Molecular Diagnostics Technology market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global POCT Molecular Diagnostics Technology Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global POCT Molecular Diagnostics Technology Market, Segmentation by Type
Molecular Point-of-Care Diagnostics
Near-Patient Molecular

Global POCT Molecular Diagnostics Technology Market, Segmentation by Application
Microbiology Laboratory
Hospital
Clinic

Companies Profiled:
Ustar Biotechnologies (Hangzhou) Ltd.
Cepheid
Abbott Laboratories
Roche Holding AG
BioFire Diagnostics
Beijing Bohui Innovat Biotech Grp Co Ltd.
CapitalBio Corporation
Daan Gene
Sansure Biotech
Coyote Bioscience Co., Ltd.
Genmark Diagnostics, Inc.
Mobidiag
Wondfo

Key Questions Answered

1. How big is the global POCT Molecular Diagnostics Technology market?

2. What is the demand of the global POCT Molecular Diagnostics Technology market?

3. What is the year over year growth of the global POCT Molecular Diagnostics Technology market?

4. What is the total value of the global POCT Molecular Diagnostics Technology market?

5. Who are the major players in the global POCT Molecular Diagnostics Technology market?

6. What are the growth factors driving the market demand?